{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T13:06:55Z","timestamp":1771852015788,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.leukres.2015.10.007","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T17:13:23Z","timestamp":1445620403000},"page":"1462-1466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Polymorphisms within beta-catenin encoding gene affect multiple myeloma development and treatment"],"prefix":"10.1016","volume":"39","author":[{"given":"Aleksandra","family":"Butrym","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Rybka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"\u0141acina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"G\u0119bura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Frontkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Bogunia-Kubik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2015.10.007_bib0005","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00277-014-2063-7","article-title":"Expression of cereblon protein assessed by immunohistochemical staining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma","volume":"93","author":"Huang","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2015.10.007_bib0010","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1212\/01.WNL.0000146196.01316.A2","article-title":"A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation","volume":"63","author":"Higgins","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.leukres.2015.10.007_bib0015","first-page":"287","article-title":"What is the functional role of the thalidomide binding protein cereblon?","volume":"2","author":"Chang","year":"2011","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"10.1016\/j.leukres.2015.10.007_bib0020","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a primary target of thalidomide teratogenicity","volume":"327","author":"Ito","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.leukres.2015.10.007_bib0025","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/leu.2012.119","article-title":"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide","volume":"26","author":"Lopez-Girona","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2015.10.007_bib0030","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1242\/jcs.039842","article-title":"The catenin family at a glance","volume":"123","author":"McCrea","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.leukres.2015.10.007_bib0035","series-title":"Multiple Myeloma: Symptoms, Diagnosis and Treatment","first-page":"51","article-title":"Wnt signaling pathways in multiple myeloma","author":"Qiang","year":"2009"},{"key":"10.1016\/j.leukres.2015.10.007_bib0040","doi-asserted-by":"crossref","first-page":"9439","DOI":"10.1007\/s13277-014-2433-8","article-title":"Wnt\/\u03b2-catenin pathway in bone cancers","volume":"35","author":"Tian","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.leukres.2015.10.007_bib0045","doi-asserted-by":"crossref","first-page":"11009","DOI":"10.1074\/jbc.M110.180208","article-title":"Evidence of a role for activation of Wnt\/\u03b2-catenin signaling in the resistance of plasma cells to lenalidomide","volume":"286","author":"Bjorklund","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2015.10.007_bib0050","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1182\/blood-2008-12-194290","article-title":"Aurora kinase A is a target of Wnt\/\u03b2-catenin involved in multiple myeloma disease progression","volume":"114","author":"Dutta-Simmons","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.10.007_bib0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.9735\/0975-2862.4.3.99-110","article-title":"Molecular genetics of intellectual disability with special emphasis on the idiopathic type","volume":"4","author":"Das","year":"2012","journal-title":"Int. J. Genet."},{"key":"10.1016\/j.leukres.2015.10.007_bib0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000133994","article-title":"Assignment of the human beta-catenin gene (CTNNB1) to 3p22\u2192p21.3 by fluorescence in situ hybridization","volume":"70","author":"van Hengel","year":"1995","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.leukres.2015.10.007_bib0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/geno.1996.0136","article-title":"Genomic organization of the human \u03b2-catenin gene (CTNNB1)","volume":"32","author":"Nollet","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.leukres.2015.10.007_bib0070","doi-asserted-by":"crossref","first-page":"e93841","DOI":"10.1371\/journal.pone.0093841","article-title":"Association of genetic variants in Wnt signaling pathway with tuberculosis in Chinese Han population","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2015.10.007_bib0075","doi-asserted-by":"crossref","first-page":"e59555","DOI":"10.1371\/journal.pone.0059555","article-title":"Association of Single nucleotide polymorphisms in Wnt signaling pathway genes with breast cancer in saudi patients","volume":"8","author":"Alanazi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2015.10.007_bib0080","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/mutage\/ges027","article-title":"Genetic variation of CTNNB1 gene is associated with susceptibility and prognosis of gastric cancer in a Chinese population","volume":"27","author":"Wang","year":"2012","journal-title":"Mutagenesis"},{"key":"10.1016\/j.leukres.2015.10.007_bib0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40291-013-0059-y","article-title":"An analysis of polymorphisms within the Wnt signaling pathway in relation to ovarian cancer risk in a Polish population","volume":"18","author":"Mostowska","year":"2014","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.leukres.2015.10.007_bib0090","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.leukres.2015.10.007_bib0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/bjh.12622","article-title":"Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity","volume":"164","author":"Gandhi","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2015.10.007_bib0100","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2012-06-438101","article-title":"High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance","volume":"121","author":"Broyl","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.10.007_bib0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.leukres.2013.08.015","article-title":"The clinical significance of cereblon expression in multiple myeloma","volume":"38","author":"Schuster","year":"2014","journal-title":"Leuk. Res."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212615305324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212615305324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T07:53:52Z","timestamp":1537257232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212615305324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0145212615305324"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2015.10.007","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymorphisms within beta-catenin encoding gene affect multiple myeloma development and treatment","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2015.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}